BenevolentAI
advanced laboratory capabilities help move programmes faster and generate data at scale for continuous innovation advanced capabilities and technologies fully equipped laboratory facilities biology chemistry highly experienced scientists across all drug discovery disciplines in house investment in and human capabilities robust and secure data storage capacity access to the institute research facility with state of the art high content imaging and capabilities cros and academic collaborations complement and extend internal capabilities the institute campus experimental capabilities enhance entire drug discovery process mechanism selection target cation target triage and experimental validation model enabled design make test cycle closing the data loop experimental data from hypothesis validation work portfolio projects and disease relevant expression data are integrated back to further enrich the knowledge graph and our representation of human biology work progresses rapidly from in silico to in experimental test dynamic experimental feedback loop between scientists technologists | BenevolentAI
Company
Deck Type
Deck date
December 2021
Slide
15 of 42
Similar slides by BenevolentAI
Investor Presentation
October 2022
Investor Day
September 2022
Related slides by other companies
Investor Presentation
August 2022
Other recent decks by BenevolentAI
Results
March 2024
Investor Conference
January 2024
Investor Presentation
May 2023
Results
March 2023
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2023 Slidebook.io